Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Business Of Biotech
00:00
The Tipping Point in the ADC Space
Cancer still remains highly on medical need. And even though there are major advances in the last decade or so, helping a lot of patients, yet there's still room for improvement. So I feel that the sum of all parts of our technology allows for safer, better, efficacious drugs. But we have not been in the clinic yet. We haven't proven it in humans, but so far so good. All the preclinical work supports the different parts of ourTechnology and that it should be safer and more efficacious.So I'm really excited about that. And you know, we're trying to make paradigm shifting therapeutics and I feel this can be it.
Transcript
Play full episode
